Shire to Present at 33rd Annual J.P. Morgan Healthcare Conference
LEXINGTON, Massachusetts, January 6, 2015 /PRNewswire/ --
Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that Flemming Ornskov, MD, Chief Executive Officer, will present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 13, 2015 at 3:00 p.m. PT (6:00 p.m. ET).
A live audio webcast will be available on the Presentations and Webcasts section of Shire's Investor website at http://www.shire.com/shireplc/en/investors/presentationswebcasts.
Subsequently, a replay of the webcast will be available on this same website for approximately 90 days.
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal, and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.
For further information please contact:
Investor Relations
Sarah Elton-Farr
seltonfarr@shire.com
+44-1256-894157
Media
Jessica Cotrone
jcotrone@shire.com
+1-781-482-9538
Stephanie Fagan
sfagan@shire.com
+1-201-572-9581
Share this article